Wire Stories
-
844WNS-Denali & CIPS Collaborate to Identify Attributes of High-Performance Procurement
BELLEVUE, Wash.–(BUSINESS WIRE)–#AlparKamber–WNS-Denali, an established leader in global sourcing and procurement solutions, has released a Benchmark Study on procurement performance and team...
-
873
Highway Holdings Appoints New Directors
Highlights Company’s Efficiency and Competitive Position HONG KONG–(BUSINESS WIRE)–Highway Holdings Limited (Nasdaq:HIHO) today announced its board of directors has appointed two new...
-
840
Robots Help to Fight Coronavirus Worldwide � International Federation of Robotics
FRANKFURT, Germany–(BUSINESS WIRE)–#americafirst—Robots play an important role in fighting the coronavirus SARS-CoV-2 around the globe. Disinfection robot UVD for example has been...
-
774
Connected Consumer Survey 2019 – TV & Video Services in Australia & New Zealand – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “The Connected Consumer Survey 2019: TV and Video Services in Australia and New Zealand” report has been added to ResearchAndMarkets.com’s...
-
833
Kurita Water Industries Announces Merger of Its U.S. Subsidiaries
Newly formed Kurita America aims to change how water treatment solutions are designed and delivered NAKANO-KU, Japan–(BUSINESS WIRE)–Kurita Water Industries, (Kurita), a...
-
848
MUFG Appoints New Members to Global Advisory Board
TOKYO–(BUSINESS WIRE)–MUFG is pleased to announce today the appointment of two new members to its Global Advisory Board: Ms. Anne Le Lorier,...
-
769
MetLife Foundation Commits $25 Million to Global COVID-19 Response
HONG KONG–(BUSINESS WIRE)–MetLife Foundation yesterday announced that it is committing $25 million to the global response to COVID-19 in support of communities...
-
849
KKR Appoints Hidekazu Harada as Managing Director in Japan
TOKYO–(BUSINESS WIRE)–KKR, a leading global investment firm, today announced the appointment of Hidekazu Harada as a Managing Director on KKR’s Private Equity...
-
869
Modalis Obtains Access to Foundational CRISPR IP
Modalis Therapeutics and Editas Medicine conclude license TOKYO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–#CRISPR–Modalis Therapeutics Corporation (Modalis) today announced that the company has entered...
-
789
Notice Regarding Business Alliance Between Sanbio and Ocumension in the Research, Development and Commercialization of Innovative Stem Cell Therapies for Ophthalmic Diseases
TOKYO–(BUSINESS WIRE)–SanBio Co., Ltd. (Keita Mori, Representative Director and President, hereinafter “SanBio”) (TOKYO:4592) hereby announces that SanBio has entered into a business...
